698 related articles for article (PubMed ID: 18574767)
1. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease.
Levy YS; Bahat-Stroomza M; Barzilay R; Burshtein A; Bulvik S; Barhum Y; Panet H; Melamed E; Offen D
Cytotherapy; 2008; 10(4):340-52. PubMed ID: 18574767
[TBL] [Abstract][Full Text] [Related]
2. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats.
Ben-Hur T; Idelson M; Khaner H; Pera M; Reinhartz E; Itzik A; Reubinoff BE
Stem Cells; 2004; 22(7):1246-55. PubMed ID: 15579643
[TBL] [Abstract][Full Text] [Related]
3. Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: limitations for autologous cell replacement strategies.
Hermann A; List C; Habisch HJ; Vukicevic V; Ehrhart-Bornstein M; Brenner R; Bernstein P; Fickert S; Storch A
Cytotherapy; 2010; 12(1):17-30. PubMed ID: 19878082
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
Blandini F; Cova L; Armentero MT; Zennaro E; Levandis G; Bossolasco P; Calzarossa C; Mellone M; Giuseppe B; Deliliers GL; Polli E; Nappi G; Silani V
Cell Transplant; 2010; 19(2):203-17. PubMed ID: 19906332
[TBL] [Abstract][Full Text] [Related]
5. Combined treatment of neurotrophin-3 gene and neural stem cells is ameliorative to behavior recovery of Parkinson's disease rat model.
Gu S; Huang H; Bi J; Yao Y; Wen T
Brain Res; 2009 Feb; 1257():1-9. PubMed ID: 19111525
[TBL] [Abstract][Full Text] [Related]
6. Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease.
Cova L; Armentero MT; Zennaro E; Calzarossa C; Bossolasco P; Busca G; Lambertenghi Deliliers G; Polli E; Nappi G; Silani V; Blandini F
Brain Res; 2010 Jan; 1311():12-27. PubMed ID: 19945443
[TBL] [Abstract][Full Text] [Related]
7. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of human multipotent mesenchymal stromal cells combined with pharmacologically active microcarriers transplanted in hemi-parkinsonian rats.
Delcroix GJ; Garbayo E; Sindji L; Thomas O; Vanpouille-Box C; Schiller PC; Montero-Menei CN
Biomaterials; 2011 Feb; 32(6):1560-73. PubMed ID: 21074844
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow stromal cells as replacement cells for Parkinson's disease: generation of an anatomical but not functional neuronal phenotype.
Thomas MG; Stone L; Evill L; Ong S; Ziman M; Hool L
Transl Res; 2011 Feb; 157(2):56-63. PubMed ID: 21256457
[TBL] [Abstract][Full Text] [Related]
10. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
11. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
12. Clinical grade mesenchymal stem cells transdifferentiated under xenofree conditions alleviates motor deficiencies in a rat model of Parkinson's disease.
Shetty P; Ravindran G; Sarang S; Thakur AM; Rao HS; Viswanathan C
Cell Biol Int; 2009 Aug; 33(8):830-8. PubMed ID: 19465139
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson's disease model rats and alleviation of asymmetric rotational behavior.
Park S; Kim E; Koh SE; Maeng S; Lee WD; Lim J; Shim I; Lee YJ
Brain Res; 2012 Jul; 1466():158-66. PubMed ID: 22634376
[TBL] [Abstract][Full Text] [Related]
15. Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke.
Hayase M; Kitada M; Wakao S; Itokazu Y; Nozaki K; Hashimoto N; Takagi Y; Dezawa M
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1409-20. PubMed ID: 19436312
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
17. Coaxing bone marrow stromal mesenchymal stem cells towards neuronal differentiation: progress and uncertainties.
Chen Y; Teng FY; Tang BL
Cell Mol Life Sci; 2006 Jul; 63(14):1649-57. PubMed ID: 16786223
[TBL] [Abstract][Full Text] [Related]
18. Protection of dopamine neurons by bone marrow stromal cells.
Shintani A; Nakao N; Kakishita K; Itakura T
Brain Res; 2007 Dec; 1186():48-55. PubMed ID: 17996227
[TBL] [Abstract][Full Text] [Related]
19. Bromodeoxyuridine increases multipotency of human bone marrow-derived stem cells.
Qu TY; Dong XJ; Sugaya I; Vaghani A; Pulido J; Sugaya K
Restor Neurol Neurosci; 2004; 22(6):459-68. PubMed ID: 15798364
[TBL] [Abstract][Full Text] [Related]
20. Neurogenic potential of human mesenchymal stem cells revisited: analysis by immunostaining, time-lapse video and microarray.
Bertani N; Malatesta P; Volpi G; Sonego P; Perris R
J Cell Sci; 2005 Sep; 118(Pt 17):3925-36. PubMed ID: 16091422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
